U.S. Life Sciences Stock News

ORIC Pharmaceuticals (NasdaqGS:ORIC) reports progress in its cancer therapy pipeline, with lead drug candidates entering Phase 1b clinical trials. The company announces new collaborations with Pfizer, Bayer, and Johnson & Johnson, aimed at advancing therapies that target resistance mechanisms in cancer treatment. These developments are drawing increased investor attention as they represent material steps in ORIC Pharmaceuticals' clinical and partnership strategy. ORIC Pharmaceuticals...

Smithfield Foods (SFD) is back on investors’ radar after recent share price moves, with the stock showing mixed short term returns but stronger performance over the past month and the past three months. See our latest analysis for Smithfield Foods. The latest share price of US$25.04 sits alongside a 30 day share price return of 10.07% and a 90 day share price return of 18.50%. The 1 year total shareholder return of 24.16% points to momentum that has been building rather than fading. If recent...

Liberty Global Ltd. has reported its full-year 2025 results, with sales rising to US$4,878.5 million from US$4,341.9 million, but swinging from a net income of US$1.59 billion to a very large net loss of US$7.14 billion and a basic loss per share from continuing operations of US$20.86. The combination of higher revenue and a very large reported loss raises questions about cost structure, one-off charges, and how resilient the business model really is. We’ll now consider how this sharp move...

Many investors are asking whether Welltower's current share price is aligned with its underlying value, or whether expectations have moved ahead of the fundamentals. The stock last closed at US$208.19, with a 1 year return of 42.6% and a 3 year return that is very large at around triple the starting point. This kind of performance can change how the market views both its growth potential and its risk profile. Recent headlines around Welltower have focused on portfolio activity, capital...

ARMOUR Residential REIT (NYSE:ARR) reported robust Q4 2025 results, highlighting portfolio growth and higher book value. The company affirmed its dividend, signaling confidence in the stability of its payout. Management outlined updated plans for capital deployment and risk management in what it views as a supportive market backdrop. The portfolio update included a focus on lower coupon and seasoned mortgage-backed securities to address prepayment risk. ARR also raised fresh capital and...

Red Rock Resorts has already reported its fourth-quarter and full-year 2025 results, showing higher revenue but slightly lower quarterly net income, and its board declared a US$1.00 per Class A share special cash dividend payable on February 27, 2026 to stockholders of record on February 20, 2026. Alongside these results, the company highlighted record fourth-quarter gaming performance in Las Vegas and outlined expansion projects and active capital allocation, underscoring management’s focus...

In February 2026, Getty Realty Corp. completed a follow-on equity offering of 4,000,000 common shares at US$32.48 per share, raising about US$129.92 million through forward sale agreements with JPMorgan Chase Bank and Wells Fargo Bank to fund acquisitions, debt repayment, and general corporate purposes. This fresh equity capital sits alongside recently reported full-year 2025 results showing higher revenue and net income year on year, and a reaffirmed quarterly dividend of US$0.485 per...

In February 2026, Bausch Health Companies reported fourth-quarter 2025 revenue of US$2,796 million and a net loss of US$112 million, alongside full-year 2025 revenue of US$10.27 billion, net income of US$157 million, and a US$145 million goodwill impairment, while also issuing 2026 revenue guidance of US$10.63–US$10.88 billion. A day later, the company and its OraPharma dental unit marked the 25th anniversary of ARESTIN, currently the only FDA-approved locally applied antibiotic adjunct for...

In February 2026, Regency Centers Corporation filed an omnibus shelf registration that covers common and preferred stock, depositary shares, warrants, purchase contracts, units, and debt securities of Regency Centers, L.P., giving it the legal framework to issue a wide range of securities as needed. This broad shelf registration expands Regency Centers’ optionality for future financing or corporate actions, which investors often watch closely for signals about potential development,...

Why insiders are buying Conduent stock after recent EBITDA progress Recent insider share purchases at Conduent (CNDT), including buying by the CEO and a director, have drawn attention as the company reports higher full year 2025 adjusted EBITDA and improved margins despite lower revenue. See our latest analysis for Conduent. The insider buying comes after a sharp move in the 1 day share price return of 11.19% and a 7 day gain of 3.58%, although the 1 year total shareholder return of 57.6% and...

Caris Life Sciences: Event Context and Recent Share Performance Caris Life Sciences (CAI) has drawn investor attention recently as its share price has moved from a last close of US$19.53 while posting negative returns over the past week, month, and past 3 months. See our latest analysis for Caris Life Sciences. The recent 1 day share price return of a 6.33% decline, alongside a 30 day share price return of a 21.88% decline and year to date share price return of a 27.61% decline, suggests...

Ramaco Resources (METC) has been drawing attention after a sharp decline in its share price over the past month, even as its past 3 months return, one year total return, and longer term performance figures remain positive. See our latest analysis for Ramaco Resources. The recent 40.26% 1 month share price decline to US$16.56 sits against a much stronger backdrop, with a 1 year total shareholder return of 73.74% and multi year total shareholder returns still firmly positive. This suggests...

If you are wondering whether Ovintiv's share price still offers value at current levels, it helps to step back and look at what the market might be pricing in. The stock closed at US$50.58, with returns of 7.8% over the last 7 days, 23.3% over the last 30 days, 24.9% year to date, 20.3% over 1 year, 20.9% over 3 years, and 147.0% over 5 years. Recent news around Ovintiv has largely focused on its position in the US energy sector and how investors are weighing commodity price moves against...

If you are wondering whether Birkenstock Holding is fairly priced or offering value right now, this article will walk through what the current numbers actually say about the stock. At a last close of US$40.89, the shares show a 2.7% return over the past 7 days, 3.4% over the last 30 days, and a 2.1% decline year to date, with a 21.1% decline over the past year adding extra interest around where value might sit today. Recent coverage has focused on Birkenstock Holding as a listed footwear...

If you are looking at InterDigital and wondering whether the recent share price really reflects its underlying worth, you are not alone. The stock last closed at US$358.50, with a 1 year return of 72.7% and a 3 year return that is more than 4x, even after a 4.4% pullback over the past week and an 8.5% gain across the last 30 days. Recent news coverage has focused on InterDigital’s role in wireless and video technology licensing and its activity in intellectual property agreements. This helps...

CBRE Group (NYSE:CBRE) has acquired Pearce Services, expanding its reach in data center solutions. The deal adds field services and technical capabilities that support data center operations. CBRE continues to invest in AI and technology to improve service delivery and efficiency. These moves come as companies face macroeconomic challenges and look to outsource more real estate and technical functions. CBRE Group, a global commercial real estate services firm, now has an expanded foothold...

Praxis Precision Medicines (NasdaqGS:PRAX) has submitted two NDAs for ulixacaltamide and relutrigine, moving its lead programs toward potential commercialization. The FDA has granted breakthrough therapy designation to ulixacaltamide, signaling regulatory focus on the drug's potential for patients with neurological disorders. The NDAs are supported by positive Phase III data, and the company is preparing for its first commercial launches, with additional pivotal readouts planned for...

First Financial Bancorp (FFBC) has attracted fresh attention after a period of solid share performance, with recent returns over the past month and past 3 months prompting a closer look at how the bank’s fundamentals compare. See our latest analysis for First Financial Bancorp. At a share price of $30.36, First Financial Bancorp’s recent momentum is reflected in a 30 day share price return of 13.11% and a 90 day share price return of 24.94%. The 1 year total shareholder return of 16.58%...

The Morning Bull - US Market Morning Update Monday, Feb, 23 2026 US stock futures are pointing lower this morning, with E mini S&P 500 and Nasdaq 100 contracts both down around 0.5% as investors absorb fresh tariff and inflation signals. A key pressure point is the US decision to lift global tariffs to 15%, which effectively makes imported goods more expensive and can squeeze profit margins for companies that rely on overseas supply chains. At the same time, the Fed’s preferred inflation...

A10 Networks (NYSE:ATEN) has outlined a clear capital allocation plan that includes potential acquisitions in next generation networking and security. The company plans to prioritize organic growth while also returning capital to shareholders. The new framework was set out by the Chief Financial Officer as a guide for how future cash resources may be used. A10 Networks, trading at $19.98, sits in a part of the market that often receives attention when security and network performance are in...

In February 2026, Highwoods Properties, Inc. filed a US$300 million at-the-market follow-on common equity offering after updating its shelf registration, shortly after reporting fourth-quarter 2025 sales of US$203.36 million and net income of US$29.23 million. The combination of income-focused equity issuance capacity and a return to quarterly profitability, despite slightly lower sales, highlights how Highwoods is balancing funding flexibility with earnings performance. Next, we’ll examine...

A class action lawsuit was filed in the past against AMC Entertainment Holdings and certain officers, alleging federal securities law violations tied to AMC Preferred Equity Units issued between August 2022 and November 2023, particularly around disclosures on APE holders’ rights after conversion to common stock. The complaint centers on an alleged loophole that left some converted APE holders out of specific distributions, prompting affected investors to consider joining the case ahead of...

In early February, analysts at J.P. Morgan and UBS reiterated Hold ratings on Regions Financial while upgrading their outlook on the bank amid a supportive regulatory backdrop and steady sector fundamentals, even after the company’s fiscal Q4 2025 results missed estimates. At the same time, Regions’ dividend profile, including a US$0.26 per share payout and several increases over recent years, has helped underpin investor confidence despite mixed earnings. With recent analyst commentary...

If you are looking at Bitdeer Technologies Group and wondering whether the recent share price reflects a fair value, you are not alone. The stock last closed at US$7.78, after share price returns of a 22.8% decline over 7 days, a 46.5% decline over 30 days and a 32.6% decline year to date, with a 40.6% decline over the past year and a 26.9% decline over three years. Recent news coverage has focused on Bitdeer Technologies Group as a listed player in the broader software and crypto...